View Thread

Journal of Operations Management Special Issue on the Operations and Supply Chains of Pharmaceutical Products: March 31 deadline

  • 1.  Journal of Operations Management Special Issue on the Operations and Supply Chains of Pharmaceutical Products: March 31 deadline

    Posted 22 days ago

    OSCM Colleagues, please read below:

     

    Do you conduct research in the pharmaceutical industry? Does your research involve the pharmaceutical products' operations and supply chains, broadly defined? If so, we would like to encourage you to submit a paper to our special issue on the operations and supply chains of pharmaceutical products, in the Journal of Operations Management. The Journal of Operations Management is a top journal in most business schools, holding the Association of Business Schools' ABS 4* (highest, "World Elite") ranking, and being listed on the two most commonly-used business school journal lists: Financial Times 50 and the UT Dallas 24. The deadline is March 31, 2023.

     

    The supply chains of pharmaceutical products have many unique features worthy of study. They were critical to the successful vaccine rollouts in many countries. The supply chains are often opaque, prone to shortages and undetected quality variation. The supply chains are typically long, spanning many countries. Middlemen in the supply chains-between manufacturers and consumers-wield tremendous power, affecting the incentives of all players. The supply chains are highly regulated.

     

    Given these characteristics, we are hoping to assemble a cross-disciplinary set of papers, as these supply chains are affected not just by production and supply chain decisions but also top management, marketing, and R&D within the firm; and global regulators, trade negotiators, middlemen, pharmacies, doctors, and consumers, outside the firm. Thus, beyond scholars of operations management, we hope to hear from scholars in other disciplines who do research in areas that may affect the operations and supply chains of pharmaceutical products. Please feel free to share.  

     

    Regards,

    John

     


    John V. Gray

    Professor, Operations and Business Analytics Department

    Part-Time Consultant, Office of Science and Technology Policy (OSTP), Executive Office of President (White House)
    612 Fisher Hall, 2100 Neil Avenue, Columbus, OH 43210
    614-247-8021 Office / 614-292-1272 Fax
    gray.402@osu.edu ; https://fisher.osu.edu/people/gray.402